Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levels

被引：0
|
作者：
Havel, RJ
机构：
来源：
CIRCULATION | 1997年 / 96卷 / 07期
关键词：
editorials; coronary disease; cholesterol fibrates;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2113 / 2114
页数：2
相关论文
共 50 条
  • [1] OBSERVATIONS ON THE VARIATION OF TOTAL SERUM CHOLESTEROL LEVELS IN NORMAL INDIVIDUALS AND IN PATIENTS WITH CORONARY HEART DISEASE
    THOMPSON, JS
    ABRAHAM, A
    ELIAS, AW
    SCOTT, CC
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1959, 237 (03): : 319 - 322
  • [2] Knowledge of cholesterol targets and levels in patients with coronary heart disease
    Cheng, S
    Lichtman, JH
    Amatruda, JM
    Smith, GL
    Yaari, S
    Krumholz, HM
    AMERICAN HEART JOURNAL, 2002, 144 (05) : 918 - 918
  • [3] LOWERING CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE - THE 4S TRIAL SHOWED THAT LOWERING HIGH CHOLESTEROL LEVELS IMPROVES SURVIVAL IN PATIENTS WITH CORONARY HEART-DISEASE - DO THE BENEFITS EXTEND TO THOSE WITH AVERAGE CHOLESTEROL LEVELS
    AYLWARD, P
    COLQUHOUN, D
    GLASZIOU, P
    HARRIS, P
    HUNT, D
    KEECH, A
    MACMAHON, S
    SHARPE, N
    SIMES, J
    THOMPSON, P
    THOMSON, A
    TONKIN, A
    WEST, M
    WHITE, H
    MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (09) : 455 - 456
  • [4] BENEFITS OF EXERCISE IN NORMAL SUBJECTS AND IN PATIENTS WITH CORONARY HEART-DISEASE
    JUNEAU, M
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1988, 37 (10): : 609 - 613
  • [5] Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and ''normal'' cholesterol levels - A randomized, placebo-controlled trial
    Pasternak, RC
    Brown, LE
    Stone, PH
    Silverman, DI
    Gibson, CM
    Sacks, FM
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 529 - +
  • [6] Cholesterol treatment levels in high risk patients for coronary heart disease.
    Ball, B
    Hopkins, PN
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 90A - 90A
  • [7] Changing Cholesterol Levels and Coronary Heart Disease Risk
    Wilson, Peter W. F.
    CIRCULATION, 2016, 133 (03) : 239 - 241
  • [8] Increase in circulating levels of adiponectin by statin and fibrate in patients with coronary artery disease
    Nakamura, T
    Kodama, Y
    Takano, H
    Umetani, K
    Mende, A
    Ichigi, Y
    Kawabata, K
    Kitta, Y
    Yoshida, H
    Kugiyama, K
    CIRCULATION, 2004, 110 (17) : 144 - 144
  • [9] Cost-effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels
    Glasziou, PP
    Mulray, SE
    Hall, JP
    Martin, A
    Harris, P
    Thompson, P
    Tonkin, A
    Simes, RJ
    MEDICAL DECISION MAKING, 1998, 18 (04) : 475 - 475
  • [10] Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
    Johannesson, M
    Jonsson, B
    Kjekshus, J
    Olsson, AG
    Pedersen, TR
    Wedel, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05): : 332 - 336
12345